As GLP-1s redefine the treatment landscape for obesity, they are also promising candidates to influe...
The next frontier in clinical trials: navigating multi-disease research with GLP-1s
As GLP-1s redefine the treatment landscape for obesity, they are also promising candidates to influence a wide range of disease pathways.
Author: PMLiVE
Read Original Article